Participant exclusion criteria in treatment research on neurological disorders: Are unrepresentative study samples problematic?

Contemporary Clinical Trials

Volumn 44, Issue , 2015, Pages 20-25

  Trivedi, Ranak B ^a,b   Humphreys, Keith ^a,b  

^a VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

Effectiveness; Exclusion criteria; Neurological disorders

Indexed keywords

ALCOHOL ABUSE; ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CLINICAL ASSESSMENT; CLINICAL RESEARCH; CLINICAL TRIAL (TOPIC); COGNITIVE DEFECT; COMORBIDITY; DEMENTIA; DRUG MISUSE; EPILEPSY; ETHNIC GROUP; EXPERIMENTAL THERAPY; EXTERNAL VALIDITY; HUMAN; MASS SCREENING; MEDICAL HISTORY; MEDLINE; MENTAL DISEASE; NARRATIVE; NEUROLOGIC DISEASE; PATIENT SELECTION; POPULATION; RACE DIFFERENCE; SUBSTANCE ABUSE; TRAUMATIC BRAIN INJURY; TREATMENT RESPONSE;

EID: 84937152323     PISSN: 15517144     EISSN: 15592030     Source Type: Journal    
DOI: 10.1016/j.cct.2015.07.009     Document Type: Article

References (31)

1. Family Caregiver Alliance Incidence and Prevalence of the Major Causes of Brain Impairment 2013, (Accessed February 12, 2015).
2. Hirtz D., Thurman D.J., Gwinn-Hardy K., Mohamed M., Chaudhuri A.R., Zalutsky R. How common are the "common" neurologic disorders?. Neurology 2007, 68(5):326-337.
3. World Health Organization Neurological Disorder: Public Health Challenges 2006, WHO Press.
4. Baquet C.R., Commiskey P., Daniel Mullins C., Mishra S.I. Recruitment and participation in clinical trials: socio-demographic, rural/urban, and health care access predictors. Cancer Detect. Prev. 2006, 30(1):24-33.
5. Anand R., Hartman R., Sohn H., Danyluk J., Graham S.M. Impact of study design and patient population on outcomes from cholinesterase inhibitor trials. Am. J. Geriatr. Psychiatry Mar-Apr 2003, 11(2):160-168.
6. Britton A., McKee M., Black N., McPherson K., Sanderson C., Bain C. Threats to applicability of randomised trials: exclusions and selective participation. J. Health Serv. Res. Policy Apr 1999, 4(2):112-121.
7. Humphreys K., Weingardt K.R., Horst D., Joshi A.A., Finney J.W. Prevalence and predictors of research participant eligibility criteria in alcohol treatment outcome studies, 1970-98. Addiction Sep 2005, 100(9):1249-1257.
8. Van Spall H.G., Toren A., Kiss A., Fowler R.A. Eligibility criteria of randomized controlled trials published in high-impact general medical journals: a systematic sampling review. JAMA 2007, 297(11):1233-1240.
9. Maas A.I., Steyerberg E.W., Marmarou A., et al. IMPACT recommendations for improving the design and analysis of clinical trials in moderate to severe traumatic brain injury. Neurotherapeutics Jan 2010, 7(1):127-134.
10. Humphreys K.N. A review of the impact of exclusion criteria on the generalizability of schizophrenia treatment research. Clin. Schizophr. 2015, (in press).
11. Moher D., Liberati A., Tetzlaff J., Altman D.G., Group T.P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009, 6(6).
12. Condon J.T. The 'unresearched'-those who decline to participate. Aust. N. Z. J. Psychiatry Mar 1986, 20(1):87-89.
13. Almici M., Sartori S., Lombardi F., Bonomini C., Geroldi C., Zanetti O. Too many hidden patients. The exclusion of individuals with Alzheimer's disease from Alzheimer's disease pharmacological clinical trials. J. Am. Geriatr. Soc. Aug 2012, 60(8):1596-1597.
14. Schneider L.S., Olin J.T., Lyness S.A., Chui H.C. Eligibility of Alzheimer's disease clinic patients for clinical trials. J. Am. Geriatr. Soc. Aug 1997, 45(8):923-928.
15. Cooper C., Ketley D., Livingston G. Systematic review and meta-analysis to estimate potential recruitment to dementia intervention studies. Int. J. Geriatr. Psychiatry May 2014, 29(5):515-525.
16. Slieker F.J., Kompanje E.J., Murray G.D., et al. Importance of screening logs in clinical trials for severe traumatic brain injury. Neurosurgery Jun 2008, 62(6):1321-1328. (discussion 1328-1329).
17. Luoto T.M., Tenovuo O., Kataja A., Brander A., Ohman J., Iverson G.L. Who gets recruited in mild traumatic brain injury research?. J. Neurotrauma 2013, 30(1):11-16.
18. da Conceicao P.O., Nascimento P.P., Mazetto L., Alonso N.B., Yacubian E.M., de Araujo Filho G.M. Are psychiatric disorders exclusion criteria for video-EEG monitoring and epilepsy surgery in patients with mesial temporal sclerosis?. Epilepsy Behav. May 2013, 27(2):310-314.
19. Tlusta E., Handoko K.B., Majoie M., Egberts T.C., Vlcek J., Heerdink E.R. Clinical relevance of patients with epilepsy included in clinical trials. Epilepsia Aug 2008, 49(8):1479-1480.
20. Chio A., Canosa A., Gallo S., et al. ALS clinical trials: do enrolled patients accurately represent the ALS population?. Neurology 2011, 77(15):1432-1437.
21. Folstein M., Folstein S., McHugh P. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 1975, 12(3):189-198.
22. Taylor J.S., DeMers S.M., Vig E.K., Borson S. The disappearing subject: exclusion of people with cognitive impairment and dementia from geriatrics research. J. Am. Geriatr. Soc. Mar 2012, 60(3):413-419.
23. Lyketsos C., Kozauer N., Rabins P.V. Psychiatric manifestations of neurologic disease: where are we headed?. Dialogues Clin. Neurosci. 2007, 9:111-124.
24. Freedman L.S., Simon R., Foulkes M.A., et al. Inclusion of women and minorities in clinical trials and the NIH Revitalization Act of 1993-the perspective of NIH clinical trialists. Control. Clin. Trials Oct 1995, 16(5):277-285. (discussion 286-279, 293-309).
25. Yancey A.K., Ortega A.N., Kumanyika S.K. Effective recruitment and retention of minority research participants. Annu. Rev. Public Health 2006, 27:1-28.
26. Ford J.G., Howerton M.W., Lai G.Y., et al. Barriers to recruiting underrepresented populations to cancer clinical trials: a systematic review. Cancer 2008, 112(2):228-242.
27. Zulman D.M., Sussman J.B., Chen X., Cigolle C.T., Blaum C.S., Hayward R.A. Examining the evidence: a systematic review of the inclusion and analysis of older adults in randomized controlled trials. J. Gen. Intern. Med. Jul 2011, 26(7):783-790.
28. Maas A.I., Roozenbeek B., Manley G.T. Clinical trials in traumatic brain injury: past experience and current developments. Neurotherapeutics Jan 2010, 7(1):115-126.
29. Peto R., Collins R., Gray R. Large-scale randomized evidence: large, simple trials and overviews of trials. J. Clin. Epidemiol. Jan 1995, 48(1):23-40.
30. Grill J.D., Galvin J.E. Facilitating Alzheimer disease research recruitment. Alzheimer Dis. Assoc. Disord. Jan-Mar 2014, 28(1):1-8.
31. Yamal J.M., Robertson C.S., Rubin M.L., Benoit J.S., Hannay H.J., Tilley B.C. Enrollment of racially/ethnically diverse participants in traumatic brain injury trials: effect of availability of exception from informed consent. Clin. Trials Apr 2014, 11(2):187-194.